医学
免疫学
病毒学
重组DNA
免疫原性
接种疫苗
抗体
免疫系统
疫苗效力
不利影响
临床试验
免疫
免疫
作者
Karen J. Hager,Gonzalo Pérez Marc,Philipe Gobeil,Ricardo S. Diaz,Gretchen Heizer,Conrado Llapur,Alexander I. Makarkov,Eduardo Vasconcellos,Stéphane Pillet,Fernando Riera,Pooja Saxena,Priscila Geller Wolff,Kapil Bhutada,Garry Wallace,Hessam Aazami,Christine E. Jones,Fernando P. Polack,Luciana Ferrara,Judith Atkins,Iohann Boulay
标识
DOI:10.1056/nejmoa2201300
摘要
The CoVLP+AS03 vaccine was effective in preventing Covid-19 caused by a spectrum of variants, with efficacy ranging from 69.5% against symptomatic infection to 78.8% against moderate-to-severe disease. (Funded by Medicago; ClinicalTrials.gov number, NCT04636697.).
科研通智能强力驱动
Strongly Powered by AbleSci AI